MoneyWorks4Me

Alivus Life Sciences informs about disclosure

21 Mar 2026 Evaluate
Pursuant to regulation 30(2) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (LODR Regulations) read with clause 20 of Para A of Part A of Schedule III of the LODR Regulations, Alivus Life Sciences has informed that the details of Intimation/Order received by the Company from Income Tax Department is enclosed as Annexure A.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1843.75
Dr. Reddys Labs. 1215.65
Cipla 1389.90
Lupin 2065.00
Zydus Lifesciences 1223.70
View more..